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Abstract 
With the coronavirus disease 2019 (COVID‑19) pandemic showing no signs of abating, resuming neglected tropi‑
cal disease (NTD) activities, particularly mass drug administration (MDA), is vital. Failure to resume activities will not 
only enhance the risk of NTD transmission, but will fail to leverage behaviour change messaging on the importance 
of hand and face washing and improved sanitation—a common strategy for several NTDs that also reduces the risk 
of COVID‑19 spread. This so‑called “hybrid approach” will demonstrate best practices for mitigating the spread of 
severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) by incorporating physical distancing, use of masks, 
and frequent hand‑washing in the delivery of medicines to endemic communities and support action against the 
transmission of the virus through water, sanitation and hygiene interventions promoted by NTD programmes. Unless 
MDA and morbidity management activities resume, achievement of NTD targets as projected in the WHO/NTD Road‑
map (2021–2030) will be deferred, the aspirational goal of NTD programmes to enhance universal health coverage 
jeopardised and the call to ‘leave no one behind’ a hollow one. We outline what implementing this hybrid approach, 
which aims to strengthen health systems, and facilitate integration and cross‑sector collaboration, can achieve based 
on work undertaken in several African countries.
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Background
We have described the world as being “assaulted by 
COVID-19” [1]. The term ‘post-COVID-19’ has been 
used to provide assurance the assault will end, the impact 
will be temporary, and a post coronavirus disease 2019 
(COVID-19) world will emerge. It is now clear, how-
ever, that COVID-19 is endemic globally and that the 
desired world will not emerge in the foreseeable future 
in the absence of a vaccine as effective as smallpox or 
polio although there is current optimism that a vaccine 
may be efficacious. Even with an effective vaccine we 
will need to learn to live with COVID-19. At the time of 
writing, Europe is experiencing a ‘second spike or surge’ 
of infection with similar resurgence patterns in many 
countries, albeit on different scales [2]. While the situa-
tion in some countries, like India and Latin America are 
of increasing concern, in the African continent COVID-
19 appears to be at less of a public health risk than feared 
although as pointed out by the WHO African Regional 
Director health services are being impacted with declines 
in malaria treatment, skilled attendance at births and 
outpatient consultations as measured in 14 African 
countries [3]. There was a 50% reduction in the services 
World Health Organization Regional Office for Africa 
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(WHO AFRO) monitored; over 1.3 million missed their 
first measles vaccination and in Nigeria 360 000 women 
missed ante-natal care and the number of maternal 
deaths in health facilities doubled compared with 2019 
[3].
While we are hopeful that recent trends in Africa con-
tinue to stabilise and decline, global models have under-
lined the potential and disproportionate health impact of 
COVID-19 on low and middle income countries (LMIC) 
[4]. The longer-term economic implications for Africa 
have also been analysed in a United Nations Confer-
ence on Trade and Development (UNCTAD) report [5] 
(https ://uncta d.org/en/Publi catio nsLib rary/aldcm isc20 
20d3_en.pdf) which predicts a reduction of 1.4% of gross 
domestic product (GDP), with the countries with smaller 
economies being more severely impacted:
“Mainly a result of export adjustments affecting pri-
mary commodity exporters, and the attendant losses 
to tax revenue which reduce the capacity of govern-
ment to extend public services necessary to respond 
to the crisis. Overall, this paper estimates a regional 
average of about 5% in public revenue losses in 
Africa, with total merchandise exports contracting 
by about 17%.”
Clearly, social consequences because of recession-
ary forces have the potential to adversely affect the 
most vulnerable. The grouping of diseases under one 
NTD umbrella was developed because of the low level 
of resource provided for conditions which dispropor-
tionately affect “the bottom billion”, given only 0.6% of 
Official Development Assistance (ODA) was devoted to 
interventions addressing these conditions, estimated to 
be afflicting up to two billion people [6, 7]. As it has been 
predicted that COVID-19 will enhance global inequity 
particularly in LMICs, it is essential that neglected tropi-
cal disease (NTD) programmes, with recognised success 
over the past decade, remain on the health and develop-
ment agenda given their key role in promoting many of 
the Sustainable Development Goals [8]. Ehrenberg et al. 
[9] have recently summarised the relevant strategies that 
can support the control of the neglected tropical diseases 
in the context of the COVID-19 challenge with a focus on 
the zoonotic origins of the virus and the need for multi-
sectoral approaches, exemplifying how synergies can be 
achieved to further efforts against NTDs.
The speed of viral spread across the globe suggests the 
fundamental biological characteristics of severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) are 
the same everywhere. It is biologically unlikely that in 
Africa SARS-CoV-2 has or will change its characteristics 
of infectivity, modes of transmission, or spectrum of clin-
ical presentations—from asymptomatic at one extreme 
through to serious, life-threatening and fatal outcomes 
on the other whilst displaying the capacity for the virus 
to mutate and cross and re-cross the species barriers as 
shown in mink farms in Denmark [10].
The true prevalence of COVID-19 globally is likely 
to be much higher than published data, as reported by 
model analysis [11]. Given the varied quality of surveil-
lance, the extent and effectiveness of testing, the accuracy 
of certification of the cause of death (if any) as well as the 
paucity death reporting, particularly in rural settings, the 
true situation is not known despite the suggestion, that 
to date, COVID-19 has not impacted on Africa as might 
have been expected or predicted [1, 3]. As the virus is 
now endemic COVID-19 mitigation strategies will there-
fore become the new normal for all medical interventions 
and consultations as well as public health programmes, 
including NTD programmes. Daily new global confirmed 
cases are around 300 000, with India and the USA repre-
senting most of the new cases, followed by Brazil, Mex-
ico and other South American countries but significant 
spikes throughout Europe have generated “lockdowns” 
of varying degrees of severity and duration. The north-
ern hemisphere winter period is also creating a spike in 
the pandemic in Europe and the USA. The Johns Hop-
kins Coronavirus Resource Center provides the real time 
country global updates [2]. While confidence in case 
reporting remains a concern, a plausible explanation for 
why Africa has apparently seen a greater success in slow-
ing the spread of the virus is due to a greater adherence to 
the recommended preventative practices. There are also 
fewer super-spreader events documented. Such events 
are fuelled by increased travel during holiday periods and 
crowding in indoor settings like bars, restaurants, and 
indoor stadiums. Africa also has a proportionately larger 
rural community than other geographies—an advantage 
as most cases and local transmission have been primarily 
confined to urban areas. The median age of African pop-
ulations is significantly lower than in Europe as pointed 
out in [1] at around 20 in Africa and 45 in Europe. Given 
most COVID-19 deaths are occurring in the post 65 
cohort then the case fatality in Africa would be expected 
to be lower.
Neglected tropical disease activities
Given the pandemic status of COVID-19, the response 
must be global. Countries should be learning from the 
experiences of others. Much is often made of what LMIC 
can learn from health services and systems in high-
income countries but the response to the pandemic is an 
opportunity to re-address this flow of experience. Africa 
has well developed community health programmes that 
deliver at scale while engaging with their communi-
ties. As outlined above, NTD programmes have utilised 
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the health messaging and behaviour change work that 
formed part of their portfolio to develop clear COVID-
19 messaging. Crisp [12] highlights, for example, that we 
should deal with health in rich and poor countries in the 
same way, not treating them as totally different, and sug-
gests that instead of talking about international devel-
opment we should talk about co-development where 
learning goes both ways; he adds community health pro-
grammes in Africa developed a community-based and 
directed approach to the treatment of NTDs—the princi-
ples of which are relevant to any health setting [12].
Any protracted suspension of NTD activities, particu-
larly MDA, will not only have a detrimental impact by 
enhancing the risk of NTD transmission, but will fail to 
leverage behaviour change messaging on the importance 
of hand and face washing and improved sanitation—a 
common strategy for several NTDs that also reduces the 
risk of COVID-19 spread [1, 13]. It also misses the oppor-
tunity for NTD programmes to mitigate the spread of the 
virus amongst health workers, while building resilience 
in responding to future emerging infectious diseases and 
to alleviate possible secondary health impacts thwarting 
progress to universal health coverage (UHC) [1, 13].
School-based NTD delivery programmes form an 
important part of NTD distribution strategies. While 
school openings have been staged over time in response 
to reduced COVID-19 risk, the large gathering of stu-
dents and teachers increases the risk of transmission and 
enhances wider virus dissemination. If a policy decision 
has been made by national authorities to open schools it 
would seem logical for those involved with NTD MDA 
that distributing treatments in schools via social distanc-
ing methods can also reinforce COVID-19 prevention 
messages while house-to-house community distribution 
ensures children withheld from school are covered as 
well.
We consider that the full resumption of NTD interven-
tions will not increase the risk of spreading SARS-CoV-2 
given the use by government of risk assessment tools to 
recognise and mitigate risk using agreed standard oper-
ating procedures (SOPs), particularly when governments 
have made the decision to ease lockdown constraints, 
open schools, resume other health services, allow move-
ment via transport, and permit mass gatherings to take 
place.
NTD programmes have long acknowledged the need 
to work across borders to control and eliminate dis-
eases. The African Programme for Onchocerciasis Con-
trol (APOC) first started to advocate for this approach in 
1995 which was been continued by the Expanded Special 
Project for the Elimination of NTDs (ESPEN) through, 
for example, cross-border disease maps on the ESPEN 
data base [16]. The examples of cross-border working on 
NTDs are numerous. One example is the case of Sierra 
Leone, Liberia and Guinea (Conakry) working on oncho-
cerciasis under the banner of the Mano River Union from 
2005 whereby coordination of treatment of border areas 
was conducted [17]. The management of cross-border, 
be they internal or international borders, is one of the 
most complex development issues to manage [18] but if 
taken seriously at the beginning of the planning stage and 
throughout implementation the mechanisms required 
can be utilised not only for NTDs but other health inter-
ventions. Sierra Leone, for example, in the COVID-19 
pandemic has been able to pivot the structures on NTDs 
in the border areas in terms of community sensitisation. 
Ghana has set up community information points on 
the Ghana-Togo border and to train border community 
health staff on disease control measures.
Given the mitigation strategies being proposed by 
national NTD programmes as precautionary measures 
(e.g. facial covering for all community drug distribu-
tors, intensified handwashing practices, maintenance of 
physical distancing practices, etc.), the commencement 
of NTD programmes will have minimal risk in spread-
ing the virus. The NTD platforms provide the opportu-
nity to actively reinforce COVID-19 prevention practices 
via community distributors who have the influence and 
respect of their communities often distant from formal 
health facilities [14]. The continued suspension of MDA 
is not logical against this background. The NTD Model-
ling Consortium has projected the impact of suspension 
of MDA on transmission and the consequential delay in 
achieving the targets set in the new WHO/NTD Road-
map [15]. The results indicate that interruption of MDA 
activities will have varying impacts on established tar-
gets depending on the duration of any treatment delays, 
the specific disease targeted, initial baseline prevalence 
and the history of effective MDA, in particular, cover-
age. However, the ability of national governments to 
retain high levels of “enforcement”/lockdown has prob-
ably reached a limit in terms of social acceptability given 
the economic impact. Governments across the globe are 
being pressed to ease the critical and necessary public 
health restrictions associated with lockdown primarily 
for economic and social reasons, in fear of greater eco-
nomic damage but also because of potential social unrest 
as is currently occurring in Lagos, Nigeria. However, in 
the northern hemisphere it is clear the second surge or 
spike commenced in late September/early October.
Ascend programme and response to COVID‑19: 
“flexing” towards a “hybrid” approach
The Foreign, Commonwealth and Development Office 
supports the Ascend programme led by Sightsavers in 
partnership with The Schistosomiasis Control Initiative 
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Foundation, the Centre for Neglected Tropical Diseases, 
Liverpool School of Tropical Medicine, M & C Saatchi 
and Mott MacDonald and with the Ministries of Health 
of partner governments. In response to COVID-19 two 
approaches have been the basis of the response (1) risk 
mitigation methodologies and processes to maximise 
safety and reduce COVID-19 transmission risk to allow 
countries to decide on the resumption of NTD activi-
ties, and (2) ascend and partners have created appropri-
ate country and sub-national specific health messaging 
through billboards, radio and TV slots in 11 countries. 
The examples of the materials developed, tested and 
displayed in the figures below. The rapid deployment of 
this educational and communication material to enhance 
adherence to the necessary behaviour change was facili-
tated by the existing Ascend NTD programme which 
adapted or “flexed” its resources working with national 
Ministries and local partners.
Introduction to risk assessment mitigation action 
tools in the context of COVID‑19
In July, the World Health Organization (WHO) provided 
interim guidance on Considerations for implement-
ing mass treatment, active case‐finding and population-
based surveys for neglected tropical diseases in the 
context of the COVID-19 pandemic [19]. This guidance 
proposed a two part decision-making framework: (1) a 
risk–benefit assessment, to decide if the planned activity 
should proceed; and (2) an examination of a list of pre-
cautionary measures that should be applied with the aim 
of decreasing the risk of transmission of COVID-19 asso-
ciated with the activity, and strengthening the capacity of 
the health system to manage any residual risk.
In following WHO’s additional guidance on adjust-
ing public health and social measures in the context of 
COVID-19 [20] (16 April 2020), countries that adapt 
public health and social measures (PHSM) should apply 
a standard methodology such as the WHO rapid risk 
assessment of acute public health events [21]. The WHO 
mass gathering COVID-19 risk assessment tool—Generic 
events [21] provides such a standard methodology and 
structure for authorities and event organizers plan-
ning mass gatherings during the current COVID-19 
pandemic.
Working amongst various NGDO and govern-
ment partners, the Ascend West and Central Africa 
programme quickly adapted in order to navigate the 
uncertainty of the pandemic in March and April 2020. 
Countries wishing to restart NTD activities could be 
accommodated by a process that gave them the best 
chance of doing so successfully, whilst at the same time 
“flexing” the programme to focus on developing and dis-
seminating COVID-19 prevention-related Behaviour 
Change and Communication (BCC) materials. By adapt-
ing an existing WHO risk assessment tool for mass gath-
erings, the Ascend West and Central Africa programme 
was able to specifically address key considerations for 
NTDs through the creation of the Risk Assessment and 
Mitigation Action (RAMA) tools for the resumption of 
MDA, surgery, and surveys. These tools ensured that 
countries would identify COVID-19-related risks and 
install proficient mitigating actions.
Sightsavers and partners have adapted the generic tool 
and methodologies to specifically address key considera-
tions for neglected tropical diseases. This includes three 
risk assessment and mitigation action (RAMA) tools:
• RAMA I: Distribution of treatments.
• RAMA II: Active case finding and surgical outreach 
for trichiasis and hydrocele surgeries.
• RAMA III: Population-based surveys.
In line with WHO guidance [20–22], adjusting any 
Public Health and Social Measures (PHSM) should be 
considered at the sub-national level starting in areas 
with lowest incidence of COVID-19. Where feasible, 
resumption of activities should be conducted in a con-
trolled, measured, and stepwise manner. To ensure that 
the resumption of NTD activities is undertaken as safely 
as possible, ascend recommends that national NTD pro-
grammes and partners use the RAMA tools as part of 
a more comprehensive seven stage risk management 
approach (Fig.  1) to ensure compliance with the WHO 
guidance, including close monitoring of COVID-19 
trends, independent verification and evaluation of writ-
ten standard operating procedures (SOPs), confirma-
tion of mitigation budget and availability of any required 
personal protective equipment (PPE), and completion of 
additional security risk assessments. Upon conclusion of 
the planned activity an updated COVID-19 trend report 
is submitted, along with results of routine monitoring 
and evaluation of activities. As a result of this process, 
since July 2020, seven separate requests to resume NTD 
activities have been processed and activities successfully 
completed, including MDAs and disease specific assess-
ments supported under the Ascend, Accelerate and 
GiveWell programmes. Many more requests have been 
approved and are under consideration showing that there 
is a clear pathway for NTD activities to resume safely 
despite the uncertain context of COVID-19.
Behaviour change messaging: ascend project 
experiences in West and Central Africa
The far-reaching and hard-hitting implications of the 
COVID-19 pandemic struck at a time when the Ascend 
West  NTD programme  was nearing the end of its first 
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year of activities.  A contingency plan was developed 
which included identifying a set of opportunities where 
Ascend competencies, experience, and ability to innovate 
in contributing towards the COVID-19 response efforts 
was developed. To formulate the country proposals 
extensive collaborations were required across the consor-
tium, with ministries and partners.
Risk communication and behaviour change was a com-
mon theme requested by Ministries from 10 of the coun-
tries (Benin, Burkina Faso, Chad, Cote d’Ivoire, DRC, 
Ghana, Guinea, Liberia, Nigeria, Sierra Leone). The 
activities for each country were unique and designed to 
fit with the need in country at that time (Fig. 2).
Process
The process for developing the communication cam-
paigns started with scoping sessions. It was necessary to 
understand where the need for communication materials 
was in terms of geography and demographics, protective 
behaviours and communication channels. Discovery ses-
sions were then held with the Ministries, where Ascend 
teams learnt about communications that had been 
developed to date, their successes, their shortfalls and 
then discussed what may be required in terms of Social 
Behaviour Change and Communication (SBCC) materi-
als. These conversations were then distilled into scopes 
of work for each country, which included a recommenda-
tion on media channels, what quantity of materials would 
be required, what languages should be used and also 
whether accessibility adapts would be required e.g. cap-
tions on videos or the inclusion of signers.
In conjunction with the scoping exercise, we developed 
a communications strategy for each country, using key 
local insights from the Ministries of Health and in-coun-
try teams. This strategy reflected the key messages and 
protective behaviours upon which the Ministry wished 
to focus. Three strategic territories were  developed—
Truth,  Play  your Part and Protection. We found that 
although each of the countries had unique challenges and 
barriers there were some common “universal truths” in 
all countries.
After receiving approval on the strategy and terri-
tory the local agency was briefed in each country using 
the insights we had gleaned from the process to date. 
The local agencies then proposed with different crea-
tive routes that could answer our brief, each pulling on 
different emotions and cultural truths and all seeking 
to increase motivation to uptake protective behaviours. 
These concepts were then presented back to the Minis-
try for their input and feedback. It was at this stage teams 
were able to focus on how we could make the commu-
nications as inclusive as possible. Considerations were 
made for literacy, legibility and representation within all 
the communications. Revised creative feedback was pre-
sented to the Ministries up to three times before the pro-
duction was commenced including filming, photography, 
illustration, and copywriting.
Outputs
The communications campaigns across the nine coun-
tries with M & C Saatchi World Services support include 
a wide variety of creative assets. This includes television 
commercials, radio spots, billboards, banners, training 
guides, fliers, training videos, influencer videos and social 
media assets. The expected reach is over 100 million peo-
ple which based on projected figures of the estimated the 
cumulative audience size of each media.
These figures will be supplemented with a phone 
survey to 300 participants in each country that will be 
conducted by Geopoll, a third party research company. 
This survey will measure impacts such as awareness, 
motivation to take action, after hearing the advertising 
Fig. 1 Example: RAMA tool as part of a comprehensive approach to the resumption of NTD activities. RAMA risk assessment and mitigation action, 
SOP standard operating procedures, COVID-19 coronavirus disease 2019
Page 6 of 13Molyneux et al. Infect Dis Poverty            (2021) 10:1 
materials, and some softer measures from beneficiar-
ies around resonance and relevance.
Key challenges and successes
A key challenge in this process was establishing who 
was responsible from within the Ministries to take 
part in the conversations and who had authority and 
the ultimate sign off on any decision. It is necessary to 
have the people that are making decisions present in 
the (virtual) room; without engagement from these key 
stakeholders early in the process sign off later could 
be problematic and time consuming. The successes 
became apparent when the Ministry identified a spe-
cific audience for communications during the initial 
discovery sessions which enabled the campaigns to 
be tailored almost entirely to their needs and cultural 
nuances.
Selected figures of the material developed are shown 
in Figs. 3, 4, 5 and 6.
Tentative time horizons: looking into the crystal 
ball
The short term
In the short term, unless MDA and morbidity manage-
ment activities resume, achievement of NTD targets as 
projected in the new WHO/NTD Roadmap (2021–2030) 
will be deferred, the aspirational goal of NTD pro-
grammes to enhance UHC will be jeopardised, essential 
medicines will not be delivered to the poorest and ‘leave 
no one behind’ will become a hollow call. Any signifi-
cant delay may require additional rounds of MDA or the 
consideration of twice-yearly MDA which will involve 
significant cost increases but initial baseline prevalence, 
historic coverage and the disease and its epidemiology 
will be the determinants. Resumption of MDA with the 
necessary risk assessment process in place is showing 
that an important health intervention can be restarted at 
limited risk and with potentially huge benefits.
Failing to complete MDA will deprive populations 
of essential drugs and, ironically, leave them further 
Fig. 2 Map showing activities underaken in Ascend West and Central Africa’s Covid‑19 response in 2020
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Fig. 3 Guinea poster. Poster created for ANSS and Health Service in Guinea, headline reads ‘We can all be champions’ by covering your mouth and 
nose you can stop the spread of COVID‑19
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behind! Sightsavers, as a key player in the NTD sphere, 
and prominent in the Accelerate and Ascend West and 
Central Africa programmes, has already published docu-
ments on the COVID-19/NTD scenarios [1, 15].
The organization has already collaborated widely 
with countries to develop risk assessment and mitiga-
tion action (RAMA) tools for national NTD programme 
managers and partner/donor representatives to assess 
together the specific risk of COVID-19 on the delivery 
of NTD treatments and to determine the overall risk of 
spreading the virus with specific mitigation measures in 
place (see above).
With the RAMA tools we have shown the COVID-19 
crisis need not allow the major health issues that con-
front poor and vulnerable populations to be forgotten. 
Indeed, the resilience of health interventions, exemplified 
by NTD projects, to manage and implement integrated 
disease control responses should be the model for pro-
gress compatible with other public health programmes 
and interventions. We, therefore, show a reassessment 
of the status of NTD activities to ensure that within the 
limits of practicable safe approaches, activities can be 
reinstated. For example, in rural settings where MDA for 
NTDs has been a critical driver of success through strong 
community engagement, providing access ‘beyond the 
end of the road’ to many millions distant from formal 
health services. NTD/MDA and seasonal malaria chemo-
therapy (SMC) and immunisation programmes can work 
together to ensure the most vulnerable are not deprived 
of access to life-saving interventions.
The resumption of these activities will have a dramatic 
impact, in particular, for SMC and children’s immunisa-
tion, decreasing risk of mortality in a group less vulner-
able to the impact of COVID-19 and calm any knock-on 
effect to the current public health crisis. However, there 
will be increased costs associated with the resumption of 
MDA as well as increased costs of safer surgery (trichia-
sis and hydrocele) to reduce COVID-19 risks. These are 
currently estimated to be of the order of 30%—a cost that 
must be weighed against the benefits derived for those 
currently living with vision impairment, stigma and disa-
blement. The risk of epidemic measles outbreaks can be 
predicted if immunisation programmes are not speedily 
resumed with high mortality ensuing; outbreaks in sev-
eral African countries with significant mortality were 
reported by WHO in late 2019 [23]. As we have already 
stressed, implementation of MDA by communities via 
community-directed distributors (CDDs) can be a plat-
form for COVID-19 mitigation messaging while provid-
ing populations access to free medicines included on the 
WHO Essential Medicines List. CDDs have historically 
had a high proportion of women acting as MDA distribu-
tors empowered by their own communities [23].
Reassessment of country situations will be an ongo-
ing process as COVID-19 continues to have an impact 
on Africa. The virus is now endemic, and governments 
will need to adapt and balance public health priorities 
with social, political and economic impacts. Suspend-
ing health programmes will have a greater detrimen-
tal impact on health than COVID-19 in the long term, 
Fig. 4 Ghana OOH in situ. Ghana billboard created for Ghana Health Service and Goodlife. Dispelling misinformation by addressing the rumour that 
COVID‑19 was not real, head on; and showing what the protective behaviours look like
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Fig. 5 Benin religious leader guide. Front page of a guide made for endogenous religions, informing them on how to direct their communities 
and themselves to stop the spread of COVID‑19. Two additional guides were made for Christians and Muslims and distributed through community 
volunteers
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particularly on children. Implementation of NTD and 
other programmes with their extensive community reach 
and engagement with vulnerable populations is compat-
ible with COVID-19 control as articulated in previous 
Sightsavers documents [24] https ://www.sight saver s.org/
news/2020/06/water -sanit ation -hygie ne-strat egies -takli 
ng-covid -19/ and https ://www.sight saver s.org/progr 
ammes /ascen d/.
Programmes must learn to adapt strategies to COVID-
19 and plan for the medium to long-term. Partners will 
continue to articulate that MDA suspension blocks an 
opportunity for the delivery of major interventions rel-
evant to the achievement of UHC—the distribution of 
essential medicines—which when managed safely can 
benefit and mitigate COVID-19 impact. This applies, 
particularly, to the most vulnerable individuals. Prevent-
ing access to surgery to address disabling conditions (e.g. 
trichiasis and hydrocele surgery) prevents the opportu-
nity for the resumption of productive lives.
The medium term
Countries and the global health community will have bet-
ter appreciation of the real impact of COVID-19 on dif-
ferent regions, communities (urban, peri-urban, rural, 
migratory populations) and geographies of Africa and of 
the impact of lockdowns on the spread of the virus; we 
reiterate that one size does not nor will not fit all sce-
narios [1]. The impact of any reduction in immunisation 
coverage will become evident with potential increases 
in measles cases; similarly, it will be important to evalu-
ate any change in malaria cases and under-five mortality. 
Greater coordination and cooperation between NTD and 
other programmes could be a positive impact of COVID-
19 on the health system itself [9]. The broader impact on 
the human resources of the health systems and where the 
critical capacity is needed will also be evident. ‘Hotspot’ 
countries and localities within countries at the highest 
risk will have been identified where specific mitigation 
measures might be necessary following any suspension of 
MDA [25].
The longer term
It is likely that the acute impact of COVID-19 will have 
passed but that the implications of political decisions will 
be clear and the new normal of a new endemic virus—
the ‘chronic COVID-19 pandemic’ recognised. Given the 
fragility of many African health systems and the human 
resource and knowledge constraints, planning a way for-
ward will be necessary. The NTD community has strong 
foundations of skilled personnel within countries who 
can show the necessary leadership qualities to address 
this new environment. Such leaders can assert that failing 
Fig. 6 Democratic Republic of Congo (DRC) TV stills. Still images from Lingala TVC ‘Telemela’ (meaning stop in Lingala), created for Health Service in 
DRC. Using popular actress and comedian Mere Bipendu to teach young children and the wider community, in the rural provinces, how to protect 
themselves from COVID‑19
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to deliver interventions that address the needs of the 
poorest is contrary to human rights law, is unethical, and 
fails to recognise their benefits in COVID-19 mitigation. 
The NTD community reach and the ‘beyond MDA’ sup-
plementary interventions (hand/face washing/limb care, 
sanitation) are powerful COVID-19 mitigating factors 
readily applicable and presently receiving donor support.
Discussion
We categorise what we believe are the “unknowns” 
and “knowns” in the current COVID-19 context. The 
unknowns are the true case numbers of COVID-19 in 
Africa and the excess deaths associated with COVID-
19. Given the variable quality of surveillance, the extent 
and effectiveness of testing as well as the cause of death 
and the paucity death reporting, particularly in rural set-
tings, the true situation cannot be known. This is despite 
the suggestion that to date, COVID-19 has not impacted 
on Africa as might have been expected. We are unsure 
of how rapidly COVID-19 will spread given the differ-
ent national responses to easing lockdown and in differ-
ent African eco-geographies—one size is unlikely fit all 
scenarios.
The impact the focus of health authorities on COVID-
19 will have on those most vulnerable in Africa, par-
ticularly children under five  years of age (Under 5  s) if 
programmes are suspended or delayed with potential 
increases in Under five mortality remains to be elu-
cidated. It will take several months to have any data 
to make a judgement but polio eradication activities, 
malaria chemotherapy programmes, immunization pro-
grammes and NTD programmes demand an equal case 
for speedy resumption of activities.
We do not know if there will be a different impact 
given median age of African population (circa 20) being 
lower than in Europe (45) [26] for example: will there be 
higher proportion of asymptomatic carriers compared 
with Europe? In addition, will there be different ‘under-
lying health conditions’ in Africa compared with more 
developed societies, and will there be a different clinical 
impact on COVID-19 patients given the potentially high 
level of undiagnosed diabetes and hypertension in urban 
areas? An important question is are people with dis-
abilities—with visual impairments, hearing impairments, 
physical disabilities, and mental health conditions—being 
considered within the COVID-19 response as highlighted 
by the UN Secretary General’s Report [27]. We do not 
believe that these unknowns preclude the known benefits 
of resuming safety assured NTD activities. The benefits 
of delivering donated essential medicines to the poorest 
outweigh the risks given the “hybrid” benefits to the elim-
ination and control of NTDs on the one hand, and miti-
gation against the COVID-19 chronic pandemic on the 
other given the commonalities of impact on transmission 
of water, sanitation and hygiene associated interventions 
and behaviours.
However, we know that COVID-19 will behave biologi-
cally in the same way in Africa as elsewhere in terms of 
infectivity and modes of transmission; MDA activities 
can resume as soon as possible with the requisite safety 
measures in place for distributors and communities fol-
lowing risk assessment. Mitigating measures, including 
WHO guidance that at least one metre social distancing 
is recommended, although national policies may recom-
mend two metres, a norm for behaviour in most organ-
ized and socially responsible societies globally.
There will be increased costs to deliver MDAs safely as 
well as to carry out surgeries. More time will be needed 
so resources may need to be redeployed. However, as 
NTD programmes address the most vulnerable, dis-
advantaged and those with disabilities—the so called 
“bottom billion”—there is an ethical and human rights 
element to activate programmes. MDA prevents chronic 
disabilities as well as providing other synergistic health 
benefits; hence, resumption of activities is a health as 
well as a development pre-requisite in the broader con-
text of the sustainable development goals (SDGs). NTD 
programmes reach beyond the ‘end of the road’ via 
community-based volunteer personnel with a proven 
track record of delivery—resources all of which can be 
harnessed now. NTD MDA in the COVID-19 era will 
provide an opportunity to enhance efficiencies through 
better inter-programme coordination, particularly with 
malaria and immunisation programmes but also as 
pointed out in [9] through greater sectoral interaction.
A principle of public health and medicine is to “do no 
harm” and “leave no-one behind”. These tenets will be 
jeopardised by a failure to resume MDA safely and sus-
pend morbidity management as both platforms can 
enhance a country response to the COVID-19 pandemic. 
The value of other NTD interventions (intensified hand-
washing practices, sanitation, safe water provision) which 
reduce transmission of both COVID-19 and NTDs are 
compatible health messages whilst NTD programmes 
also address and have experience in managing cross-
border issues. For the reasons and experience we illus-
trate we recommend this “hybrid” approach be a policy 
priority.
Conclusions
COVID-19 is now an endemic infection to which all 
health programmes will be required to adapt against a 
background of uncertainty into the foreseeable future.
In the context of NTD programmes particularly 
in Africa, we consider the additional risks of resum-
ing NTD interventions in areas where routine health 
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services are ongoing can be mitigated, negating addi-
tional risk. In doing so we must be reassured that 
programmes and activities do no harm, requiring risk 
analysis and investment in mitigation measures, despite 
increasing costs, given the biggest cost driver will be 
additional time of human resources required, a con-
clusion borne out by the ongoing Risk Assessment and 
Mitigation Actions (RAMA process).
NTD programmes offer an opportunity to reinforce 
COVID-19 response through health-impact messag-
ing. The NTD community must address this because 
any increased costs offer a potentially wider impact 
through ‘hybrid’ interventions thus being more cost-
effective. Such an approach facilitates the strengthening 
health systems, facilitating integration and cross-sector 
collaboration.
Having initiated COVID-19 flexing policies in Ascend 
West countries we are now better informed about the 
new context within which NTD interventions will 
reside. The situation will evolve over time, unpredict-
ably and according to country circumstances. This evo-
lution will not be driven by COVID-19 biology but by 
national policy responses to mitigate impact and soci-
etal adherence to behaviour change messages to stem 
transmission.
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